Axel Meye

4.0k total citations
122 papers, 3.2k citations indexed

About

Axel Meye is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Axel Meye has authored 122 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 49 papers in Pulmonary and Respiratory Medicine and 44 papers in Oncology. Recurrent topics in Axel Meye's work include Sarcoma Diagnosis and Treatment (28 papers), Cancer-related Molecular Pathways (24 papers) and RNA Interference and Gene Delivery (18 papers). Axel Meye is often cited by papers focused on Sarcoma Diagnosis and Treatment (28 papers), Cancer-related Molecular Pathways (24 papers) and RNA Interference and Gene Delivery (18 papers). Axel Meye collaborates with scholars based in Germany, United States and Netherlands. Axel Meye's co-authors include Helge Täubert, Manfred P. Wirth, Susanne Fuessel, Peter Würl, Matthias Bache, U. Schmidt, Hannelore Schmidt, Matthias Kotzsch, Frank Bartel and Kai Kraemer and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Oncogene.

In The Last Decade

Axel Meye

121 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Axel Meye Germany 34 1.7k 1.1k 844 640 376 122 3.2k
Barbara Sennino United States 28 2.0k 1.2× 1.1k 1.0× 698 0.8× 817 1.3× 284 0.8× 47 3.8k
Andrew Sullivan United Kingdom 13 1.2k 0.7× 1.5k 1.4× 501 0.6× 717 1.1× 511 1.4× 23 3.4k
Frits Thorsen Norway 36 1.6k 1.0× 955 0.9× 648 0.8× 972 1.5× 358 1.0× 84 4.0k
Alexander Berndt Germany 35 1.7k 1.0× 1.3k 1.2× 523 0.6× 656 1.0× 722 1.9× 137 4.1k
Masahiro Inoue Japan 23 2.0k 1.2× 1.3k 1.2× 652 0.8× 1.3k 2.0× 520 1.4× 49 3.9k
Omar E. Franco United States 32 1.6k 0.9× 1.3k 1.2× 1.1k 1.3× 808 1.3× 358 1.0× 80 3.5k
Byungwoo Ryu United States 20 1.7k 1.0× 1.3k 1.2× 370 0.4× 568 0.9× 394 1.0× 39 2.9k
Andreas Gäumann Germany 29 1.4k 0.9× 753 0.7× 843 1.0× 595 0.9× 247 0.7× 101 3.3k
Yuri Sheinin United States 29 1.2k 0.7× 1.1k 1.0× 867 1.0× 453 0.7× 576 1.5× 60 2.9k
Paul A. Berry United Kingdom 14 1.5k 0.9× 2.0k 1.9× 686 0.8× 820 1.3× 258 0.7× 24 3.0k

Countries citing papers authored by Axel Meye

Since Specialization
Citations

This map shows the geographic impact of Axel Meye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Meye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Meye more than expected).

Fields of papers citing papers by Axel Meye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Axel Meye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Meye. The network helps show where Axel Meye may publish in the future.

Co-authorship network of co-authors of Axel Meye

This figure shows the co-authorship network connecting the top 25 collaborators of Axel Meye. A scholar is included among the top collaborators of Axel Meye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Axel Meye. Axel Meye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meye, Axel, et al.. (2010). Serotonin and Melatonin Do Not Play a Prominent Role in the Growth of Prostate Cancer Cell Lines. Urologia Internationalis. 84(4). 452–460. 18 indexed citations
2.
Kraemer, Kai, Susanne Fuessel, & Axel Meye. (2007). Telomerase Inhibition by Synthetic Nucleic Acids and Chemosensitization in Human Bladder Cancer Cell Lines. Methods in molecular biology. 405. 9–22. 5 indexed citations
3.
Kotzsch, Matthias, Anieta M. Sieuwerts, Marianne Großer, et al.. (2007). Urokinase receptor splice variant uPAR-del4/5-associated gene expression in breast cancer: identification of rab31 as an independent prognostic factor. Breast Cancer Research and Treatment. 111(2). 229–240. 47 indexed citations
4.
Fuessel, Susanne, Axel Meye, Kai Kraemer, et al.. (2006). Synthetic Nucleic Acids as Potential Therapeutic Tools for Treatment of Bladder Carcinoma. European Urology. 51(2). 315–327. 9 indexed citations
5.
Froehner, Michael, Oliver W. Hakenberg, Rainer Koch, et al.. (2006). Comparison of the Clinical Value of Complexed PSA and Total PSA in the Discrimination between Benign Prostatic Hyperplasia and Prostate Cancer. Urologia Internationalis. 76(1). 27–30. 12 indexed citations
6.
Kraemer, Kai, U. Schmidt, Susanne Fuessel, et al.. (2006). Microarray analyses in bladder cancer cells: Inhibition of hTERT expression down‐regulates EGFR. International Journal of Cancer. 119(6). 1276–1284. 18 indexed citations
7.
Fuessel, Susanne, Axel Meye, Marc Schmitz, et al.. (2006). Vaccination of hormone‐refractory prostate cancer patients with peptide cocktail‐loaded dendritic cells: Results of a phase I clinical trial. The Prostate. 66(8). 811–821. 100 indexed citations
8.
Kotzsch, Matthias, Juliane Farthmann, Axel Meye, et al.. (2005). Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancer. European Journal of Cancer. 41(17). 2760–2768. 40 indexed citations
9.
Fuessel, Susanne, Bernd Weigle, U. Schmidt, et al.. (2005). Transcript quantification of Dresden G protein-coupled receptor (D-GPCR) in primary prostate cancer tissue pairs. Cancer Letters. 236(1). 95–104. 13 indexed citations
10.
Weigle, Bernd, Andrea Kießling, Reinhard Ebner, et al.. (2004). D‐PCa‐2: A novel transcript highly overexpressed in human prostate and prostate cancer. International Journal of Cancer. 109(6). 882–892. 5 indexed citations
11.
Meye, Axel, et al.. (2004). Induction of proliferation and differentiation of cultured urothelial cells on acellular biomaterials. British Journal of Urology. 94(6). 922–927. 19 indexed citations
12.
Täubert, Helge, Frank Bartel, Matthias Kappler, et al.. (2003). Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patients. Cancer. 97(9). 2273–2278. 16 indexed citations
13.
Förster, Yvonne, Axel Meye, Sybille Albrecht, et al.. (2003). Tissue specific expression and serum levels of human tissue factor in patients with urological cancer. Cancer Letters. 193(1). 65–73. 24 indexed citations
14.
Kießling, Andrea, Marc Schmitz, Stefan Stevanović, et al.. (2002). Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patients. International Journal of Cancer. 102(4). 390–397. 61 indexed citations
15.
Täubert, Helge, Matthias Kappler, Axel Meye, et al.. (2000). A MboII polymorphism in exon 11 of the human MDM2 gene occuring in normal blood donors and in soft tissue sarcoma patients: an indication for an increased cancer susceptibility?. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 456(1-2). 39–44. 4 indexed citations
16.
Meye, Axel, Peter Würl, Raoul Hinze, et al.. (1998). No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas. The Journal of Pathology. 184(1). 14–17. 13 indexed citations
17.
Würl, Peter, Axel Meye, Dieter Berger, et al.. (1998). Significance of retinoblastoma and mdm2 gene expression as prognostic markers for soft-tissue sarcoma. Langenbeck s Archives of Surgery. 383(1). 99–103. 17 indexed citations
18.
Täubert, Helge, Dieter Berger, Raoul Hinze, et al.. (1998). How is the mutational status for tumor suppressors p53 and p16INK4A in MFH of the bone?. Cancer Letters. 123(2). 147–151. 6 indexed citations
19.
Täubert, Helge, Axel Meye, Matthias Bache, et al.. (1998). p53 status in radiation-induced soft-tissue sarcomas. Strahlentherapie und Onkologie. 174(8). 427–430. 4 indexed citations
20.
Würl, Peter, Helge Täubert, Matthias Bache, et al.. (1996). Frequent occurrence of p53 mutations in rhabdomyosarcoma and leiomyosarcoma, but not in fibrosarcoma and malignant neural tumors. International Journal of Cancer. 69(4). 317–323. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Barbara Sennino Breakdown of academic impact, for papers by Andrew Sullivan Breakdown of academic impact, for papers by Frits Thorsen Breakdown of academic impact, for papers by Alexander Berndt Breakdown of academic impact, for papers by Masahiro Inoue Breakdown of academic impact, for papers by Omar E. Franco Breakdown of academic impact, for papers by Byungwoo Ryu Breakdown of academic impact, for papers by Andreas Gäumann Breakdown of academic impact, for papers by Yuri Sheinin Breakdown of academic impact, for papers by Paul A. Berry
Rankless by CCL
2026